FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2023/08/056138 [Registered on: 04/08/2023] Trial Registered Prospectively
Last Modified On: 04/08/2023
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   "A study to evaluate the efficacy of kharjura in Haemoglobin levels with special refernce to Rakta dhatu poshanakaala - A Clinical study" 
Scientific Title of Study   Clinical study of khajura on hemoglobin percentage with special reference to sushrutas rakta dhatu poshankal  
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Supriya P Tonge 
Designation  Associate Professor, Dept of Kriya Sharira 
Affiliation  Shri Dhanwantry Ayurvedic College and Hospital, Sector 46-B, Chandigarh 
Address  PZETs College of Ayurveda and Research Centre, Akurdi, Pune
Shri Dhanwantry Ayurvedic College and Hospital, Sector 46-B, Chandigarh
Pune
MAHARASHTRA
411044
India 
Phone  8308252487  
Fax    
Email  supriyatonge1@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Swati Chobhe 
Designation  Professor and HOD, Department of Kriya Sharira 
Affiliation  PZETs College of Ayurveda and Research Centre, Akurdi, Pune 
Address  PZET College of Ayurveda and Research Centre, Akurdi, Pune
PZET College of Ayurveda and Research Centre, Akurdi, Pune
Pune
MAHARASHTRA
411044
India 
Phone  9850716124  
Fax    
Email  swatichobhe@yahoo.com  
 
Details of Contact Person
Public Query
 
Name  Dr Swati Chobhe 
Designation  Professor and HOD, Department of Kriya Sharira 
Affiliation  PZETs College of Ayurveda and Research Centre, Akurdi, Pune 
Address  PZET College of Ayurveda and Research Centre, Akurdi, Pune
PZET College of Ayurveda and Research Centre, Akurdi, Pune

MAHARASHTRA
411044
India 
Phone  9850716124  
Fax    
Email  swatichobhe@yahoo.com  
 
Source of Monetary or Material Support  
shri dhanwantry ayurvedic college and hospital, chandigarh 
 
Primary Sponsor  
Name  Dr Supriya Tonge 
Address  At post mukutban,zari jamani, district - yavatmal,state- Maharashtra  
Type of Sponsor  Other [other(self)] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
dr Supriya Tonge  PDEAs College Of Ayurved And Research Centre  Sector No. 27, Pradhikaran, Nigdi, Pimpri-Chinchwad, Maharashtra 411044
Pune
MAHARASHTRA 
8308252487

supriyatonge1@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
PZET College of Ayurveda and Research Centre, Akurdi, Pune  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Healthy Human Volunteers  person having lower haemoglobin levels (Borderline Anaemia) with classical sign and symptoms of Raktadhatu kshaya 
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
Intervention  Group A - Khajur Laddu  Khajur Laddu of 10 gram is administered once daily with Dhatri Loha of 250mg in empty morning for 30 days  
Comparator Agent  Group B- Dhatri Loha  Dhatri Loha tablet of 250mg is administered once daily with anupana as ushna jala 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  30.00 Year(s)
Gender  Both 
Details  1. Persons with lower levels of Hb (Borderline Anaemia of Hb 10 to 11gm%)
2. Persons presenting with signs and symptoms of Raktadhatu kshaya
3. Persons having proper agni bala
4. Persons will be selected from in and around the Research site of study without any bar of race, religion and sex 
 
ExclusionCriteria 
Details  1. Persons below the age of 18years and above 30 years
2. Pregnant and lactating women
3. Persons suffering from any acute or chronic disease conditions
4. Persons suffering from Aplastic Anaemia, Pernicios Anaemia, Hemolytic Anaemia and other Haemoglobinopathies 
 
Method of Generating Random Sequence   Coin toss, Lottery, toss of dice, shuffling cards etc 
Method of Concealment   Case Record Numbers 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Khajur laddu administered as neutraceutical is effective in improving Hb percentage in samples  0th day, 5th day, 10th day, 15th day, 20th day, 25th day, 30th day with Hb evaluation 
 
Secondary Outcome  
Outcome  TimePoints 
impact of khajura as nutritional supplementation on sushrutas rakta dhatu poshankal.  0th day, 5th day, 10th day, 15th day, 20th day, 25th day, 30th day with Hb evaluation 
 
Target Sample Size   Total Sample Size="310"
Sample Size from India="310" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3/ Phase 4 
Date of First Enrollment (India)   17/08/2023 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  17/08/2023 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   none yet 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

PURPOSE OF THE STUDY

“To Assess Effect Of Khajura With Dhatriloha And Dhatriloha Alone On Haemoglobin Percentage With Special Reference To Sushrutas Rakta Dhatu Poshankal.”

 

AIM

To Compare The Effect Of Khajur With Dhatriloha And Dhatriloha Alone On Haemoglobin Percentage With Special Reference To Sushrutas Rakta Dhatu Poshankal.”

 OBJECTIVES

Ø  Primary objectives: - : To compare the effect of Khajura with dhatriloha and dhatriloha alone on Haemoglobin Percentage With Special Reference To Sushrutas Rakta Dhatu Poshankal.

Ø  Secondary objectives:- To study the impact of khajura as nutritional Supplementation on sushrutas rakta dhatu poshankal.

Tools for Primary Objectives:

1.      To assess the effect of Khajura with dhatriloha on Haemoglobin Percentage With Special Reference To Sushrutas Rakta Dhatu Poshankal.

2.      To assess Probable mode of action of Khajura with dhatriloha and dhatriloha alone on Haemoglobin Percentage With Special Reference To Sushrutas Rakta Dhatu Poshankal.

3.      To study the classical and recent literature regarding khajura, Collection and  authentication of sample khajura.

     4.      Preparation of          khajura laddu.

5.      To Revalidate the Rakta dhatu shaya lakshanas “Raktemlashishirapriti” in rakta dhatu shaya.

6.      Haemoglobin percentage was estimated by using sahli‟s haemoglobinometer or  lab test.

       7.        Complete Blood Count (CBC)

8.      To study the impact of khajura as Nutritional supplementation on Haemoglobin  level.

9.      To study the impact of khajura as Nutritional supplementation on Sushrutas Rakta Dhatu Poshan kala.

10. To study whether individual having Rakta kshaya has craving for Amlasheet Dravya.


MATERIALS AND METHOD

MATERIALS –

1.      Khajura laddu – Self Prepared by Investigator.

2.      Haemoglobin percentage - Sahli‟s Hemoglobinometer.

3.      Complete Blood Count (CBC Count)

METHODOLOGY

1)         Type of Study Design – Open Randomized Controlled clinical study

2)       Randomization procedure - Samples will be collected by Random sampling and labelled them

3)         Place of study – Researcher concern places.

4)         Duration of Study (Setting) - 3 Yrs.

5)       Statistical analysis – Inference will be drawn by applying this test – Paired„t‟ test.

6)       Sample size – 310 Patient15

 

PLAN FOR THE STUDY

Ø  The patients in the study will be selected randomly from respective study    centre in same season.

Ø  310 patient15 divided in 2 groups will be taken on the basis of inclusion and exclusion criteria i.e. assessment criteria.

Ø  Each patient will be thoroughly examined according to CRF.

Ø  Hb% and CBC count will be measured by lab test before and after 30days

Ø  Two group will be done, one group will be administered khajura with dhatriloha and another group will be administered only dhatriloha.

Ø  On every 5th day only haemoglobin percentage will be measured.

Ø  A haemoglobin level of male less than 13g/dl and female less than 12 g/dl has been defined as border line anaemia so Border line anaemic patient will be selected.

Ø  Khajura laddu in 10 gram will be administered at Rasayan kala (In early morning on empty stomach) every day total 30 day.

Ø  Duration of administration of Khajura laddu is 30 days.

Ø  The patient will be assessed on the basis of Haemoglobin percentage and grading scales are adopted to assess the grading system of rakta dhatu shaya lakshana.

 

•         Duration of treatment – 1month


 

 

 

All the selected patients fulfilling the criteria of selection will be randomly Divided into two groups –

 

I.            Group A             : This group will be termed as Experimental / Trial group.

 

a)  No. of patients              : About 155 patients

b)  Treatment : This group will be administered Khajura laddu                            with dhatriloha26

c)       Praman

1.      Khajura laddu in 10 gram of khajura laddu will be administered at Rasayan kala (in early morning on empty stomach) every day.

 

(Manufactured by company                   - Khajura marketed by                Lion

Company ISO certified- Highly accepted, rated and tested product. FSSAI certified)

 

2.      Dhatriloha - 1 tab of 250 milligram

Manufactured by company - Baidyanath Company

 

d)   Duration – 30 day

 

ii)         Group B                               : This group will be termed as control group.

 

 

a)     No of patients            : About 155 patients.

 

 

b)   Treatment                     : This group will be administrating with only

 

dhatriloha.

 

c)  Praman                        : Dhatriloha – 1 tab of 250 milligram.

 

 

d)   Duration – 30 day

 

(Dhatriloha – Ref- Bhaishajya Ratnavali Pandurogadhikar)


 

 

Treatment Schedule for 2 Groups

Screening and selection of the patients will be carried out as per inclusion and exclusion criteria.

Screening for selection criteria



Included for Study with Investigation Day 0

Randomization - Samples will be collected by Random    sampling and labelled them.

 

 

Group A Experimental Group


 

Group B control group


Follow up every day

for administration of khajura laddu.

 

On every 5th day only haemoglobin percentage will be measured also Investigation on 5th day and 30th day by lab test - hb% and CBC will be done

 

 


Statistical analysis with Appropriate test

Interpretation of Result

 

S.O.P Of Khajura Laddu :-

 

 

1)     Preparation – Self Prepared by Investigator.

2)     Procedure –

a)     Manually removal of seed from khajura.

b)     Grinding of khajura in mixer grinder.

c)      Obtaining khajura paste and then lastly prepared khajura laddu

3)     Diet – Routine diet.

 


 
Close